These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 11326167)
1. Prostate cancer: screening and early detection. Cookson MM Cancer Control; 2001; 8(2):133-40. PubMed ID: 11326167 [TBL] [Abstract][Full Text] [Related]
2. Prostate cancer and prostate-specific antigen (PSA) screening in Austria. Vutuc C; Schernhammer ES; Haidinger G; Waldhör T Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872 [TBL] [Abstract][Full Text] [Related]
3. Screening and early detection for prostate cancer. Magoha GA East Afr Med J; 1997 Oct; 74(10):664-7. PubMed ID: 9529752 [TBL] [Abstract][Full Text] [Related]
4. PSA-based screening for prostate cancer: how does it compare with other cancer screening tests? Crawford ED; Abrahamsson PA Eur Urol; 2008 Aug; 54(2):262-73. PubMed ID: 18556114 [TBL] [Abstract][Full Text] [Related]
7. [Multiparametric MRI for prostate cancer screening]. Hoeks CM; Fütterer JJ; Somford DM; van Oort IM; Huisman H; Barentsz JO Ned Tijdschr Geneeskd; 2009; 153():B487. PubMed ID: 20003566 [TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen-based screening for prostate cancer: evidence, controversies and future perspectives. Ito K Int J Urol; 2009 May; 16(5):458-64. PubMed ID: 19341365 [TBL] [Abstract][Full Text] [Related]
9. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL. Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057 [TBL] [Abstract][Full Text] [Related]
10. PSA-based screening for prostate cancer. Too many adverse effects. Prescrire Int; 2012 Sep; 21(130):215-7. PubMed ID: 23016259 [TBL] [Abstract][Full Text] [Related]
11. Critical appraisal of prostate-specific antigen in prostate cancer screening: 20 years later. Pienta KJ Urology; 2009 May; 73(5 Suppl):S11-20. PubMed ID: 19375622 [TBL] [Abstract][Full Text] [Related]
12. [Comparison between 2 techniques of screening for prostatic carcinoma. Rectal exploration and transrectal ultrasonography vs. prostate specific antigen]. Ciatto S; Bonardi R; Mazzotta A; Lombardi C; Santoni R; Cardini S; Zappa M Radiol Med; 1994 Oct; 88(4):453-7. PubMed ID: 7527916 [TBL] [Abstract][Full Text] [Related]
14. [Advancements in PSA-based screening for prostate cancer]. Ito K Rinsho Byori; 2004 Jul; 52(7):611-7. PubMed ID: 15344561 [TBL] [Abstract][Full Text] [Related]
15. Prostate cancer: a review of common underwriting problems, Part 1. Richie RC; Swanson JO J Insur Med; 2004; 36(3):242-54. PubMed ID: 15495440 [TBL] [Abstract][Full Text] [Related]
16. [New challenges and earlier approved methods in the laboratory diagnosis of prostate cancer]. Kovács GL Magy Onkol; 2014 Dec; 58(4):301-9. PubMed ID: 25517448 [TBL] [Abstract][Full Text] [Related]
17. [Prostatic specific antigen in practice in 1997]. Salomon L; Colombel M; Patard JJ; Chopin D; Abbou CC Ann Urol (Paris); 1998; 32(2):69-72. PubMed ID: 9599634 [TBL] [Abstract][Full Text] [Related]
18. [Screening for early detection of prostate cancer (first experience in Israel)]. Neheman A; Shotland Y; Metz Y; Stein A Harefuah; 2001 Jan; 140(1):4-10, 88, 87. PubMed ID: 11242898 [TBL] [Abstract][Full Text] [Related]
19. The case for prostate cancer screening. Andriole GL Semin Urol; 1993 May; 11(2):50-3. PubMed ID: 7689738 [TBL] [Abstract][Full Text] [Related]
20. [Early detection of cancer of the prostate. Pros and cons]. Hoesl CE; Altwein JE MMW Fortschr Med; 2005 Apr; 147(14):32, 34-6. PubMed ID: 15887681 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]